An analyst thinks he has cracked the code on why highflying Eli Lilly missed two quarters of Wall Street projections.

Allurion Technologies shares soared 200% Friday as it planned to test its gastric balloon with the key ingredient in popular weight-loss drugs to see if the combination improves patients' muscle mass.

When it came to beef cattle, flesh cover and quality were paramount, with little notice taken of age and moves once the ...

Akero Therapeutics shares traded near their all-time high as the drugmaker reported positive results in a study of its treatment for liver disease.

Amcor's business is driven largely by high volumes, and this is a metric the firm tracks. Read why I have upgraded AMCR stock ...

Houlihan Lokey posted solid Q3 results, but its 33.3x P/E ratio suggests limited upside. See why HLI stock is a "Hold" due to valuation concerns.

Turning Point Brands, Inc. (NYSE:TPB – Get Free Report) has been given an average rating of “Buy” by the five ratings firms that are currently covering the company, MarketBeat.com reports. Four ...

Instead of throwing away edible and nutrient-rich peel of bananas, oranges and other fruits and veg, here are five ways to ...

As technology continues to reshape financial services, regulators and policy setters are embarking on a range of ...

Netflix is also losing the crime comedy duology 21 Jump Street (85%) and 22 Jump Street (84%) which star Jonah Hill and ...

Why Michael Saylor’s MicroStrategy is a brilliant blueprint for manipulating traditional finance to harness the pixie dust of crypto mania.

Jefferies analyst Philip Ng maintained a Buy rating on Ball (BALL – Research Report) yesterday and set a price target of $80.00. The company’s ...